GENETIC POLYMORPHYSM IN THE GENE OF METHYLTETRAHYDROFOLATREDUCTAZA AND ITS IMPACT ON PLASMA HOMOCYSTEINE LEVEL AND ON LONG-TERM EFFECTS OF ACUTE MYOCARDIAL INFARCTION



Cite item

Full Text

Abstract

Hipergomocystenemia (HHC) is a significant risk factor for cardiovascular deseases. According to research in HHC incidence of acute myocardial infarction (AMI) increases by 3-4 times. There are hereditary and acquired causes of HHC. One of the reasons is the presence of inherited genetic polymorphisms in the MTHFR gene. According to research conducted by us, the level of homocysteine (HC) plasma at the time of admission was higher than the reference values in 75 % of cases (95 % CI: 60-86). On the 14th day of flow above the AMI level of HC reference values was observed in 73 % (95 % CI: 57-84) cases. The level of HC in patients with homozygous MTHFR gene polymorphism was significantly higher than in patients with heterozygous polymorphism, or without it on the first day of flow of AMI (p = 0.028), and on the 14th day course of acute myocardial infarction (p = 0.001.) In assessment of the long-term outcome after coronary flow AMI endpoints (development of re-infarction, unstable angina, stroke, repeat revascularization, death from CHD), there has been established a clear correlation between the presence of genetic polymorphisms in the MTHFR gene and the development of re-infarction (p = 0.04), the need to repeat revascularization (p = 0.003), the development of unstable angina (p = 0.001). In patients with homozygous polymorphism in the gene encoding MTHFR, re-infarction occurred more frequently (p = 0.021). These data suggest HHC, as one of the most important risk factors for AMI, as well as a higher level of HHC and more severe course of acute myocardial infarction in patients with the presence of polymorphisms in the MTHFR gene.

Full Text

ГЕНЕТИЧЕСКИЕ ПОЛИМОРФИЗМЫ МЕТИЛЕНТЕТРАГИДРОФОЛАТРЕДУКТАЗЫ И ИХ ВЛИЯНИЕ НА УРОВЕНЬ ГОМОЦИСТЕИНА ПЛАЗМЫ КРОВИ И НА ОТДАЛЕННЫЕ РЕЗУЛЬТАТЫ ТЕЧЕНИЯ ОСТРОГО ИНФАРКТА МИОКАРДА
×

About the authors

P N Mukhina

Northern State Medical University

Email: neodcray@yandex.ru

N A Vorobyova

North Branch of the Health Ministry SSC RF; Northern State Medical University; First Municipal Clinical Hospital named after E. E. Volosevicth

Arkhangelsk, Russia

I V Belyakova

Northern State Medical University

References

  1. Баркаган З. С., Момот А. П. Диагностика и контролируемая терапия нарушений гемостаза. М. : Ньюдиамед, 2008. 296 с.
  2. Беленкова Ю. Н., Оганова Р. Г. Кардиология: национальное руководство. М. : ГЭОТАР-МЕД, 2007. 1232 с.
  3. Васина Л. В. Маркеры апоптоза и дисфункция эндотелия при остром коронарном синдроме // Регионарное кровообращение и микроциркуляция. 2004. № 4 (12). С. 5-10.
  4. Костюченко Г. И., Баркаган З. С. Диагностика и методы коррекции гипергомоцистеинемии в кардиологической практике. М., 2004. 21 с.
  5. Кошелев Ю. А., Костюченко Г. И. Гомоцистеин. Роль в патологии. М., 2005. 17 с.
  6. Петрищев Н. Н. Дисфункция эндотелия. Причины, механизмы, фармакологическая коррекция. СПб., 2005. 184 с.
  7. Шмелева В. М., Папаян Л. П. Клинико-лабораторная диагностика и лечение тромбофилии, обусловленной гипергомоцистеинемией. СПб. : ФГУ «РосНИИГТ Росмедтехнологий, 2008. 34 с.
  8. Cappuccio F., Bell R.., Perry I., et al. Homocysteine levels in men and women of different ethnic and cultural background living in England // Atherosclerosis. 2002. Vol. 164 (1). P. 95-102.
  9. Gershoni-Baruch R., Dagan E., Israeli D., et al. Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women // Eur. J. Cancer. 2000. Vol. 36, N. 18. P. 2313-2316.
  10. Mager A., Battler A., Birnbaum Y., et al. Plasma homocysteine, methylenetetrahydrofolate reductase genotype, and age at onset of symptoms of myocardial ischemia // Atherosclerosis. 2002. Vol. 89(8). P. 919-923.
  11. Reyes-Engel A., Morel M., Aranda F., et al. Plasma homocysteine levels, C667T polymorphism of methylenetetrahydrofalate reductasa gene, plasma renin activity and cardiovascular risk // Am. J. Hypertens. 2002. Vol. 14(4, suppl. 1). P. A154.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2012 Mukhina P.N., Vorobyova N.A., Belyakova I.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 78166 от 20.03.2020.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies